Tri-O-benzoyl-2-O-(trifluoromethanesulfonyl)-a-D-ribofuranose, CAS:97614-41-0

[3,5-Dibenzoyloxy-4-(trifluoromethylsulfonyloxy)oxolan-2-yl]methyl benzoate, commonly known as DBO, is an ester of benzoic acid with a unique structure that holds great potential in various fields of research and industry. DBO has fascinating chemical, physical, and biological properties, which make it an exciting compound to study, characterize, and synthesize. Definition and Background DBO is an ester synthesized from benzoic acid and oxirane, which is then reacted with triflic anhydride to produce the final compound. The compound's distinctive structure and the presence of the trifluoromethylsulfonyloxy group make it attractive for various applications in organic and medicinal chemistry. Synthesis and Characterization DBO is synthesized using a modified benzoic acid-oxirane reaction in the presence of triflic anhydride. The product is purified using a column chromatography technique. DBO is characterized using various spectroscopic techniques such as Nuclear Magnetic Resonance (NMR), Infrared (IR), and Mass Spectrometry (MS). Analytical Methods Various analytical methods are utilized in detecting and quantifying the presence of DBO in different samples. Some of the techniques used include High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), and Ultraviolet-Visible Spectroscopy (UV-Vis). Biological Properties DBO exhibits a range of biological activities such as anti-inflammatory, antimicrobial, and anticancer effects. The compound has shown promising results in preclinical studies, making it an attractive candidate for further research into potential therapeutic agents. Toxicity and Safety in Scientific Experiments DBO has low toxicity and is generally safe for use in scientific experiments. However, it is essential to handle the compound with care and follow proper laboratory protocols to avoid exposure. Applications in Scientific Experiments DBO is used in various fields of scientific research, including organic synthesis, analytical chemistry, and medicinal chemistry. The compound has also shown potential as a diagnostic tool and in drug delivery systems. Current State of Research Current research on DBO focuses on its biological activity and potential as a drug candidate. The compound has shown promising results in preclinical studies, and researchers are exploring its potential use in treating diseases such as cancer and inflammatory disorders. Potential Implications in Various Fields of Research and Industry DBO has vast potential in various fields of research and industry, including organic synthesis, analytical chemistry, medicinal chemistry, and drug discovery. The compound's unique structure and biological activities make it an attractive candidate for further research. Limitations and Future Directions Like any new compound, DBO has limitations that must be addressed before it can be widely used in various fields of research and industry. Some of the future directions for research on DBO include: 1. Optimizing the synthesis process to increase yield and purity. 2. Expanding research on DBO's potential biological activities and mechanisms of action. 3. Investigating the use of DBO in drug delivery systems. 4. Exploring the use of DBO as a diagnostic tool for diseases such as cancer. 5. Enhancing the overall understanding of DBO's chemical and physical properties. Conclusion The ester [3,5-Dibenzoyloxy-4-(trifluoromethylsulfonyloxy)oxolan-2-yl]methyl benzoate, commonly known as DBO, has great potential in various fields of research and industry. The compound's unique structure and biological properties make it an attractive candidate for further study and exploration. Future research on DBO will undoubtedly lead to new insights and discoveries that will enhance our understanding of this compound and its potential applications. CAS Number 97614-41-0 Product Name [3,5-Dibenzoyloxy-4-(trifluoromethylsulfonyloxy)oxolan-2-yl]methyl benzoate IUPAC Name [3,5-dibenzoyloxy-4-(trifluoromethylsulfonyloxy)oxolan-2-yl]methyl benzoate Molecular Formula C27H21F3O10S Molecular Weight 594.51 g/mol InChI InChI=1S/C27H21F3O10S/c28-27(29,30)41(34,35)40-22-21(38-24(32)18-12-6-2-7-13-18)20(16-36-23(31)17-10-4-1-5-11-17)37-26(22)39-25(33)19-14-8-3-9-15-19/h1-15,20-22,26H,16H2 InChI Key HBSJRDYIAMPUCU-UHFFFAOYSA-N SMILES C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)OC(=O)C3=CC=CC=C3)OS(=O)(=O)C(F)(F)F)OC(=O)C4=CC=CC=C4 Canonical SMILES C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)OC(=O)C3=CC=CC=C3)OS(=O)(=O)C(F)(F)F)OC(=O)C4=CC=CC=C4 CAS No: 97614-41-0 MDL No: MFCD18643133 Chemical Formula: C27H21F3O10S Molecular Weight: 594.51 References: 1. Alauddin MM, et.al.,, Nucl. Med. Biol., 2004, 45, p2063